Product How it works Pricing Blog FAQ About Contact
Haemonetics

Haemonetics (NYSE: HAE) revenue

Haemonetics reported revenue of $1,334m for fiscal 2026, 2.0% less than in fiscal 2025 ($1,361m). Since fiscal 2017 its revenue has grown by 50.5%, an average growth of 4.7% a year.

Haemonetics's best year of the last 10 was fiscal 2025. The biggest drop was in fiscal 2021, −11.9%.

Revenue, in millions of US dollars886.12017903.92018967.62019988.52020870.52021993.220221,16920231,30920241,36120251,3342026
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2026$1,334m−2.0%$156.7m11.7%
2025$1,361m+4.0%$221.8m16.3%
2024$1,309m+12.0%$164.9m12.6%
2023$1,169m+17.7%$156.0m13.4%
2022$993.2m+14.1%$80.8m8.1%
2021$870.5m−11.9%$89.7m10.3%
2020$988.5m+2.2%$103.4m10.5%
2019$967.6m+7.0%$83.5m8.6%
2018$903.9m+2.0%$56.2m6.2%
2017$886.1m—−$19.4m−2.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Haemonetics revenue compared with its sector

By revenue for its latest fiscal year, Haemonetics ranks 134th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Haemonetics, −2.0%.

RankCompanyRevenueRevenue growth
132ndLivaNova$1,388m10.7%
133rdConmed$1,375m5.2%
134thHaemonetics$1,334m−2.0%
135thHealthEquity$1,313m9.5%
136thProgyny$1,289m10.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Haemonetics

How much revenue did Haemonetics make in fiscal 2026?
Haemonetics reported revenue of $1,334m for fiscal 2026, compared with $1,361m in fiscal 2025.
How much has the revenue of Haemonetics grown?
Between fiscal 2017 and fiscal 2026 it went from $886.1m to $1,334m: 50.5% more, an average growth of 4.7% a year.
What was the best year for revenue at Haemonetics?
Of its last 10 fiscal years, fiscal 2025, with $1,361m.
Where does Haemonetics rank in its sector by revenue?
It ranks 134th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Haemonetics come from?
From the annual report (Form 10-K) that Haemonetics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Haemonetics files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Haemonetics: the Haemonetics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.